Market Cap: $92.29M
TC
Tonix Pharmaceuticals Holding Corp.
TNXP
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $92.29M
Tonix Pharmaceuticals' New Initiative to Enhance Employee Engagement Tonix Pharmaceuticals Holding recently files for shareholder approval of a new 2026 Stock Incentive Plan, a significant step design…
Tonix Pharmaceuticals: A Strategic Uplisting and Its Implications for Growth Tonix Pharmaceuticals Inc. recently completes its uplisting to the Nasdaq Global Select Market, a significant milestone aim…
Tonix Pharmaceuticals’ Nasdaq Uplisting Marks a Strategic Milestone Tonix Pharmaceuticals Inc. achieves a significant milestone by uplisting to the Nasdaq Global Select Market, a decision aimed at boo…
Tonix Pharmaceuticals Advances Innovative Approach to Lyme Disease Treatment Tonix Pharmaceuticals Holding Corp. takes significant strides in its mission to combat Lyme disease with the development of…
Tonix Pharmaceuticals Advances Monoclonal Antibody for Lyme Disease Treatment Tonix Pharmaceuticals Holding Corp. is making strides with its innovative therapeutic candidate, TNX-4800, a long-acting h…
Tonix Pharmaceuticals Launches TONMYA: A Defining Moment for the Company Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) marks a significant milestone with the commercial launch of its new drug, TONM…
Tonix Pharmaceuticals Launches TONMYA, Signaling Growth in Pharmaceutical Market Tonix Pharmaceuticals Holding Corp announces the U.S. commercial launch of its new drug, TONMYA, marking a significant…
Vena Reinvents Social Drinking with THC-Infused Beverages In a notable development within the wellness beverage sector, Vena, a California-based brand, reintroduces its highly sought-after Happy Tonix…
Vena Revives Popular THC Seltzers and Mocktails to Meet Growing Demand for Sober-Curious Beverages Vena, a wellness brand based in Irvine, California, is making waves in the beverage industry with the…
Emerging Trends in the Wellness Beverage Market: Vena's Innovative THC Seltzers and Mocktails In recent developments within the wellness beverage sector, Vena, a California-based brand, reintroduces i…
Tonix Pharmaceuticals: Advancements in Clinical Trials Highlight Commitment to Innovation Tonix Pharmaceuticals Holding Corp. is currently making notable strides in the field of biopharmaceuticals, pa…
Tonix Pharmaceuticals Secures FDA Approval for Innovative Fibromyalgia Treatment In a landmark development, Tonix Pharmaceuticals Holding Corp. receives FDA approval for TNXP Tonmya, a sublingual form…
Tonix Pharmaceuticals Secures FDA Approval for Innovative Fibromyalgia Treatment Tonix Pharmaceuticals Holding Corp. achieves a notable milestone with the FDA's recent approval of TNXP Tonmya, a subli…
Tonix Pharmaceuticals: Anticipation Surrounds Potential Catalyst Tonix Pharmaceuticals Holding Corp is currently at the center of heightened investor interest due to speculation about an impending ann…
Tonix Pharmaceuticals Reports Impressive Growth Amid Operational Advances Tonix Pharmaceuticals Holding Corp. (TNXP) announces robust financial results for the second quarter, showcasing a notable yea…
Tonix Pharmaceuticals: Advancing Therapeutics for Pain and CNS Disorders Tonix Pharmaceuticals Holding Corp (TNXP) makes significant strides in the pharmaceutical landscape as it announces its second-…
Tonix Pharmaceuticals Accelerates Growth with Strong Operational Updates Tonix Pharmaceuticals Holding Corp. (TNXP) showcases significant strides in its operational and financial performance, demonstr…
Tonix Pharmaceuticals Faces Investor Scrutiny Following SEC Filing Tonix Pharmaceuticals Holding Corp (TNXP) experiences a significant reaction from the market following its recent filing of Form S-3…
Tonix Pharmaceuticals Faces Investor Concerns Following SEC Filing Tonix Pharmaceuticals Holding Corp (TNXP) confronts significant investor apprehension following its recent filing of a Form S-3 with…
Tonix Pharmaceuticals Faces Investor Concerns Amid SEC Filing Tonix Pharmaceuticals Holding Corp (TNXP) experiences a notable decline in stock price following the recent filing of a Form S-3 with the…
Tonix Pharmaceuticals: A Focus on Innovative Therapeutics Tonix Pharmaceuticals Corp. is at the forefront of developing novel treatments for a range of medical conditions, which positions the company…
Tonix Pharmaceuticals: Advancing Innovative Therapeutics Amid Market Volatility Tonix Pharmaceuticals Corp. is currently at the forefront of developing groundbreaking treatments for a range of medical…
Tonix Pharmaceuticals: Pioneering Innovations in Therapeutics Tonix Pharmaceuticals Corp. is gaining attention in the biotechnology sector due to its strategic focus on developing innovative treatment…
Tonix Pharmaceuticals Gains Momentum with Positive Q1 Performance Tonix Pharmaceuticals Holding Corp (TNXP) showcases significant progress as it reports positive developments in its first-quarter perf…
Tonix Pharmaceuticals Secures Positive Momentum Through First-Quarter Performance Tonix Pharmaceuticals Holding Corp demonstrates a strong upward trajectory following its recent first-quarter performa…